» Articles » PMID: 16079113

European Consensus on Grading Bone Marrow Fibrosis and Assessment of Cellularity

Overview
Journal Haematologica
Specialty Hematology
Date 2005 Aug 5
PMID 16079113
Citations 263
Authors
Affiliations
Soon will be listed here.
Abstract

Quantification of characteristic bone marrow biopsy features includes basic parameters such as cellularity and fiber content. These are important to assess the dynamics of disease processes with a significant impact on risk stratification, survival patterns and, especially, therapy-related changes. A panel of experienced European pathologists and a foreign expert evaluated, at a multi-headed microscope, a large number of representative slides of trephine biopsies from patients with myelofibrosis in an attempt to reach a consensus on how to grade cellularity and fibrosis. This included a critical evaluation of previously described scoring systems. During the microscopic analysis and subsequent discussion and voting, the importance of age-dependent decrease in cellularity was recognized. Grading of myelofibrosis was simplified by using four easily reproducible categories including differentiation between reticulin and collagen. A consensus was reached that the density of fibers must be assessed in relation to the hematopoietic tissue. This feature is especially important in order to avoid a false impression of a reduced fiber content in fatty and/or edematous bone marrow samples after treatment. The consensus for measuring myelofibrosis by clear and reproducible guidelines achieved by our group should allow for precise grading during the disease process and after therapy.

Citing Articles

Rapid Development of Unclassified Myeloid Lineage Acute Leukaemia With Trisomy 6 and U2AF1 Mutation.

Markiewicz M, Kopacz A, Blajer-Olszewska B, Mazur M, Warzybok K, Szarawarska M J Cell Mol Med. 2025; 29(5):e70461.

PMID: 40066790 PMC: 11894460. DOI: 10.1111/jcmm.70461.


Evolution of WHO diagnostic criteria in "Classical Myeloproliferative Neoplasms" compared with the International Consensus Classification.

Thiele J, Kvasnicka H, Gianelli U, Arber D, Tefferi A, Vannucchi A Blood Cancer J. 2025; 15(1):31.

PMID: 40038244 PMC: 11880409. DOI: 10.1038/s41408-025-01235-7.


Reticulin-Free Quantitation of Bone Marrow Fibrosis in MPNs: Utility and Applications.

Ryou H, Thomas E, Wojciechowska M, Harding L, Tam K, Wang R EJHaem. 2025; 6(2):e70005.

PMID: 40017714 PMC: 11866042. DOI: 10.1002/jha2.70005.


A Case of Myeloproliferative Neoplasm with Eosinophilia Associated with PCM1-JAK2 Rearrangement.

Zhou W, Guo X, Liu Y, Hao Z, Chu S, Zhang L Case Rep Oncol. 2025; 18(1):190-197.

PMID: 39980500 PMC: 11790268. DOI: 10.1159/000542692.


Distribution of different classes of CSF3R mutations and co-mutational pattern in 360 myeloid neoplasia.

Maffei R, Paolini A, Conte B, Riva G, Nasillo V, Creti F Ann Hematol. 2025; 104(1):263-274.

PMID: 39907800 PMC: 11868254. DOI: 10.1007/s00277-025-06232-1.